This Nasal Spray Rapidly Reverses Effects Of Fentanyl Overdose And No, It's Not Naloxone - Indivior (NASDAQ:INDV) benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Indivior (INDV) Announces Publication Demonstrating that OPVEE Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Indivior PLC (LSE/Nasdaq: INDV) today announced results from a pharmacodynamic study demonstrating that OPVEE® rapidly reverses opioid-induced.
This head-to-head pharmacodynamic study in healthy volunteers examined the ability of both OPVEE and intranasal naloxone to reverse opioid-induced respiratory depression, which is the shallow and slow breathing associated with an opioid overdose In this model, OPVEE 2.7mg reversed respiratory depression to 95% of pre-opioid baseline within 5 minutes; a similar reversal following a 4 […]
Drugmaker Indivior Plc clinched a US contract worth up to $111 million for its opioid antidote part of the government’s preparation for a potential bioterrorism attack with drugs such as fentanyl that can be released into the air. The contract will secure US supplies of Opvee, an opioid reversal medication that…